Pages that link to "Q37888329"
Jump to navigation
Jump to search
The following pages link to Hepatocellular carcinoma: the point of view of the hepatitis B virus (Q37888329):
Displaying 38 items.
- Mate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral Etiology (Q26799320) (← links)
- Occult hepatitis B virus infection (Q27004224) (← links)
- Update on occult hepatitis B virus infection (Q28070317) (← links)
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection (Q29615868) (← links)
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. (Q30391932) (← links)
- Occult hepatitis B virus and hepatocellular carcinoma (Q33661018) (← links)
- The intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China (Q34206628) (← links)
- Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome (Q34207805) (← links)
- Hepatitis B virus and hepatitis C virus dual infection (Q34404975) (← links)
- Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives (Q35742116) (← links)
- Demethylation of tumor necrosis factor-α converting enzyme promoter associated with high hepatitis B e antigen level in chronic hepatitis B (Q35865265) (← links)
- Establishment of drug-resistant HBV small-animal models by hydrodynamic injection (Q36237555) (← links)
- Hepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms and Novel Therapeutic Interventions (Q36281598) (← links)
- Occult HBV infection (Q36518847) (← links)
- HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations (Q37254285) (← links)
- Optimal Follow-up of Patients with Viral Hepatitis Improves the Detection of Early-stage Hepatocellular Carcinoma and the Prognosis of Survival. (Q37383131) (← links)
- SASLT practice guidelines for the management of hepatitis B virus. (Q37634822) (← links)
- Identifying the targets for treatment of liver fibrosis and hepatocellular carcinoma from both Western medicine and Chinese medicine. (Q37997974) (← links)
- Experimental models and therapeutic approaches for HBV. (Q38035173) (← links)
- Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review (Q38179533) (← links)
- How did hepatitis B virus effect the host genome in the last decade? (Q38302100) (← links)
- Molecular mechanisms underlying HBsAg negativity in occult HBV infection (Q38536404) (← links)
- The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades (Q38952536) (← links)
- Deep sequencing in the management of hepatitis virus infections. (Q39063756) (← links)
- Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine. (Q40179044) (← links)
- Hepatocellular carcinoma with concomitant hepatic angiomyolipoma and cavernous hemangioma in one patient (Q41167583) (← links)
- Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. (Q41486355) (← links)
- JSH Guidelines for the Management of Hepatitis B Virus Infection (Q42244740) (← links)
- Programmed hepatocytes cell death associated with FLIP downregulation in response to extracellular preS1/2. (Q42254676) (← links)
- A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal. (Q42263583) (← links)
- Up-regulation of brain-expressed X-linked 2 is critical for hepatitis B virus X protein-induced hepatocellular carcinoma development (Q42371584) (← links)
- The clinical significance of occult HBV infection (Q42406515) (← links)
- Human hepatocytes apoptosis induced by replication of hepatitis B virus subgenotypes F1b and F4: Role of basal core promoter and preCore mutations. (Q45325383) (← links)
- Impact of intrahepatic hepatitis B DNA and covalently closed circular DNA on survival after hepatectomy in HBV-associated hepatocellular carcinoma patients (Q51872199) (← links)
- Occult Hepatitis B Infection in the Immigrant Population of Sicily, Italy (Q59127531) (← links)
- Naturally Occurring Hepatitis B Virus Mutations Leading to Endoplasmic Reticulum Stress and Their Contribution to the Progression of Hepatocellular Carcinoma (Q64226390) (← links)
- Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection (Q92586392) (← links)
- A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries (Q97074994) (← links)